|
OMIM |
Link |
Information gain |
01 |
|
GPS
|
[NCBI]
|
0.00199053
|
|
|
prostaglandin-endoperoxide synthase deficiency
|
[NCBI]
|
0.00116883
|
|
|
HPS
|
[NCBI]
|
0.000580873
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000321712
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000210148
|
|
|
von willebrand disease
|
[NCBI]
|
0.000191019
|
|
|
CHS
|
[NCBI]
|
0.000183968
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
9.80863e-05
|
|
|
PF4
|
[NCBI]
|
8.74083e-05
|
|
|
polycythemia vera
|
[NCBI]
|
7.90172e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
7.61714e-05
|
|
|
F2R
|
[NCBI]
|
7.59999e-05
|
|
|
glycogen storage disease ib
|
[NCBI]
|
7.53072e-05
|
|
|
MHA
|
[NCBI]
|
7.44795e-05
|
|
|
F3
|
[NCBI]
|
6.96245e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
5.17899e-05
|
|
|
CPB2
|
[NCBI]
|
4.10628e-05
|
|
|
TFPI
|
[NCBI]
|
3.90978e-05
|
|
|
ZNF385
|
[NCBI]
|
3.87304e-05
|
|
|
PIK3CB
|
[NCBI]
|
3.67101e-05
|
|
|
RA
|
[NCBI]
|
3.54124e-05
|
|
|
B4GALNT2
|
[NCBI]
|
3.52081e-05
|
|
|
GP5
|
[NCBI]
|
3.40115e-05
|
|
|
P2RY1
|
[NCBI]
|
3.40115e-05
|
|
|
RABGGTA
|
[NCBI]
|
3.30166e-05
|
|
|
ENTPD1
|
[NCBI]
|
3.21651e-05
|
|
|
AKT2
|
[NCBI]
|
3.07596e-05
|
|
|
GP9
|
[NCBI]
|
3.0165e-05
|
|
|
PAPSS2
|
[NCBI]
|
2.91296e-05
|
|
|
WAS
|
[NCBI]
|
2.82805e-05
|
|
|
TBXA2R
|
[NCBI]
|
2.82488e-05
|
|
|
TPH1
|
[NCBI]
|
2.74824e-05
|
|
|
PLSCR1
|
[NCBI]
|
2.56445e-05
|
|
|
INPP5D
|
[NCBI]
|
2.42458e-05
|
|
|
ITGA2B
|
[NCBI]
|
2.42458e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.29481e-05
|
|
|
ITGB3
|
[NCBI]
|
1.95248e-05
|
|
|
HRG
|
[NCBI]
|
1.79922e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.71385e-05
|
|
|
GNAS
|
[NCBI]
|
1.65042e-05
|
|
|
VASP
|
[NCBI]
|
1.43161e-05
|
|
|
PLG
|
[NCBI]
|
1.1999e-05
|
|
|
PTH
|
[NCBI]
|
2.19581e-06
|
|
|
HGF
|
[NCBI]
|
1.07803e-06
|
|
|
APOE
|
[NCBI]
|
1.00789e-06
|
|
|
AVP
|
[NCBI]
|
1.9683e-07
|
|
|
PCNA
|
[NCBI]
|
1.39461e-07
|
|
|
VEGF
|
[NCBI]
|
4.11708e-09
|
|